Skip to main content

Posts

Featured

Psychedelic Research Targets Systemic Inflammation

My latest for Project CBD is another piece on psychedelic science. Here are the first two sentences to give you a taste:  "Medical scientists have caught on to the fact that cannabinoids help fight unwanted inflammation that contributes to many diseases. But the next anti-inflammatory wonder drug could come from an even more unexpected source: psychedelics. A team at the University of New Orleans is now working to refine one of the most potent anti-inflammatory molecules known to science, a synthetic psychedelic similar to LSD called DOI (2,5-Dimethoxy-4-iodoamphetamine)." Read the full story here .

Latest Posts

Two articles in Sonoma magazine March issue

Two new stories on psychedelic science: OCD treatment with psilocybin for Project CBD & semantics of "psychedelic" vs "hallucinogen" for Pyschedelic Science Review

Airborne COVID Spread in Multifamily Housing: An overlooked risk

Essential Fatty Acids & the Endocannabinoid System

Investigating psychedelics as a treatment for dementia and early-stage Alzheimer's Disease

COVID and disposable food packaging: a harmful, unhealthy combination

The Sequestration Solution: Whendee Silver’s research shows that compost doesn’t just benefit farmers — it captures carbon

Safe to drink: Solving the arsenic problem in groundwater

Tire Leachate, Hair Relaxers, and Detergents Enter SF Bay Through Stormwater Soup

Another from the November issue of Sonoma magazine